BrightView director receives 2,071 shares as stock compensation

BrightView Holdings, Inc. director reports stock compensation grant.

Rhea-AI Filing Summary

BrightView Holdings, Inc. director reports stock compensation grant. A BrightView Holdings, Inc. director reported acquiring 2,071 shares of common stock on 12/31/2025 at a price of $12.67 per share. These vested shares were issued as director compensation in lieu of cash, meaning the director chose to receive stock instead of a cash fee. Following this transaction, the director beneficially owned 118,004 shares of BrightView common stock in direct ownership.

Insider Trade Summary

Grant/Award: 2,071 shares

Grant/Award 1 txn

Insider SWAN MARA E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,071	$12.67	$26K

Holdings After Transaction: Common Stock — 118,004 shares (Direct)

Footnotes (1)

1. F1. Represents vested shares of Issuer common stock issued as director compensation in lieu of cash.

FAQ

What insider transaction did BrightView Holdings (BV) report in this filing?

A BrightView Holdings director reported acquiring 2,071 shares of common stock on 12/31/2025 as part of director compensation, at a price of $12.67 per share.

Was the BrightView (BV) insider transaction a purchase or compensation grant?

The filing states the 2,071 shares of BrightView common stock represent vested shares issued as director compensation in lieu of cash, not an open-market purchase.

How many BrightView (BV) shares does the reporting director own after this transaction?

After the reported transaction, the director beneficially owns 118,004 shares of BrightView Holdings common stock in direct ownership.

What is the relationship of the reporting person to BrightView Holdings (BV)?

The reporting person is identified as a Director of BrightView Holdings, Inc., with the corresponding box checked on the form.

Does this BrightView (BV) insider filing involve any derivative securities?

The section for derivative securities is present, but the provided content only shows activity in non-derivative common stock, with no derivative amounts filled in.

Is the BrightView (BV) filing made by one or multiple reporting persons?

The form indicates it is filed by one reporting person, with that option checked under the individual or joint/group filing section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/05/2026 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SWAN MARA E

(Last) (First) (Middle)

C/O BRIGHTVIEW HOLDINGS, INC.

980 JOLLY ROAD, SUITE 300

(Street)

BLUE BELL PA 19422

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightView Holdings, Inc. [ BV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/31/2025		A(1)		2,071	A	$12.67	118,004	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents vested shares of Issuer common stock issued as director compensation in lieu of cash.

	/s/ Jonathan M. Gottsegen, as Attorney-in-Fact	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.